| Description |
1 online resource (82 pages) : color illustrations, color maps |
| Contents |
Threats and Opportunities for European Pharmaceutical Wholesalers in a Changing Healthcare Environment; Table of Contents; Index of Figures; Index of Tables; Index of Abbreviations; Others; Executive Summary; 1. Introduction; 1.1 Tradition and Change; 1.2 Healthcare in Transition; 1.3 Research Objectives; 1.4 Structure; 1.5 Data Source; 2. Pharmaceutical Wholesale Distribution; 2.1 Pharmaceutical Supply Chain; 2.2 Full-line Pharmaceutical Wholesalers; 2.3 Short-line Pharmaceutical Wholesalers; 2.4 Functions of Pharmaceutical Wholesalers; 2.4.1 Bridging of Distances; 2.4.2 Bridging of Time |
|
2.4.3 Quantity Function2.4.4 Quality Function; 2.4.5 Services creating Added Value; 2.4.6 Coverage; 3. Healthcare in Transition; 3.1 Changing Demographic Composition; 3.2 Challenges in Healthcare Funding; 3.3 Cost-driven Changes; 3.3.1 Generic Market Penetration; 3.3.2 Price Erosion; 3.4 Structural Alterations in the Pharmaceutical Supply Chain; 3.4.1 Direct Deliveries; 3.4.2 Public Service Obligation; 3.4.3 Certified Supply Chain; 3.5 Transforming Healthcare Systems in CEE; 3.5.1 The Post-Semaskho Era; 3.5.2 Informal Payments and Corruption; 4. Sustainable Growth; 4.1 Outsourcing |
|
4.2 Value Added Services4.3 Vertical Integration; 4.3.1 Sweden Abolishes Pharmacy Monopoly; 4.3.2 Legislation; 4.4 Cooperation models; 4.5 Pharmerging Markets; 5. Conclusion; Bibliography; Author's Profile |
| Summary |
HauptbeschreibungThe aim of this book is to identify the major drivers of change within the European healthcare systems and to evaluate risks and opportunities confronting pharmaceutical full-line wholesalers. These businesses are the most important link between pharmaceutical manufacturing and the point of sale; providing one-stop-shopping for healthcare professionals across Europe. While on the one hand European governments are interested to ensure broad access to healthcare provision for the general public with a high level of quality, they are on the other hand concerned with limiting cost |
| Bibliography |
Includes bibliographical references |
| Subject |
Pharmaceutical industry -- Europe
|
|
MEDICAL -- Pharmacology.
|
|
Pharmaceutical industry
|
|
Europe
|
| Form |
Electronic book
|
| ISBN |
9783842821002 |
|
384282100X |
|
